Clinical Trial Update: ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ICP-332 in moderate to severe atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ICP-332

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Atopic Dermatitis | Phase 3 | Status: RECRUITING